Efficacy and safety of acamprosate in the treatment of detoxified alcohol-dependent patients: A 90-day placebo-controlled dose-finding study

British Journal of Psychiatry

Volumn 171, Issue JULY, 1997, Pages 73-77

  Pelc, I ^a   Verbanck, P ^a   Le Bon, O ^a   Gavrilovic, M ^a   Lion, K ^a   Lehert, P ^b  

^a BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

^b Facultes Universitaires Catholiques de Mons   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACAMPROSATE; DRUG DERIVATIVE; DRUGS USED IN THE TREATMENT OF ADDICTION; TAURINE; PLACEBO;

ADOLESCENT; ADULT; AGED; ALCOHOL ABSTINENCE; ALCOHOLISM; ARTICLE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; LIBIDO; MALE; MIDDLE AGED; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; TREATMENT OUTCOME; DETOXIFICATION; DRUG EFFICACY; DRUG SAFETY; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION;

ADOLESCENT; ADULT; AGED; ALCOHOL DETERRENTS; ALCOHOLISM; DIARRHEA; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LIBIDO; MALE; MIDDLE AGED; RECURRENCE; TAURINE; TEMPERANCE; TREATMENT OUTCOME;

EID: 0031182913     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.171.1.73     Document Type: Article

References (25)

1. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders (3rd edn, revised) (DSM-III-R). Washington, DC: APA.
2. Daoust, M., Legrand, B., Gewiss, M., et al (1992) Acamprosate modulates synaptosomal GABA transmission in chronically alcoholised rats. Pharmacology, Biochemistry and Behaviour, 41, 669-674.
3. De Soto, C. B., O'Donnel, W. E. & De Soto, J. L. (1989) Long term recovery in alcoholics. Alcoholism: Clinical and Experimental Research, 13, 693-697.
4. Gewiss, M., Heidbredder, C., Opsomer, L., et al (1991) Acamprosate and diazepam differentially modulate alcohol-induced behavioural and cortical alterations in rats following chronic inhalation of ethanol vapour. Alcohol and Alcoholism, 24, 129-137.
5. Gilbert, G. S. (1987) The effect of type of aftercare follow-up on treatment outcome among alcoholics. Journal of Studies on Alcohol, 49, 149-159.
6. Guy, W. (ed.) (1974) ECDUE Assessment Manual for Psychopharmacology (3rd edn). Rockville, MD: National Institute of Mental Health.
7. Hamilton, M. (1959) The assessment of anxiety states by rating. British Journal of Medical Psychology, 32, 50-55.
8. _ (1960) Rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 93, 56-61.
9. Lehert, P. (1993) Review and discussion of statistical analysis of controlled clinical trials in alcoholism. Alcohol and Alcoholism, suppl. 2, 157-163.
10. Le Magnen, J., Tran, G., Durlach, J., et al (1987) Dose dependent suppression of the high alcohol intake of chronically intoxicated rats by Ca-acetylhomotaurinate. Alcohol, 4, 97-102.
11. Lhuintre, J. P., Daoust, M., Moore, N., et al (1988) Ability of calcium bis homotaurinate, a GABA-agonist, to prevent relapse in weaned alcoholics. Lancet, i, 1014-1016.
12. _, Moore, N., Tran, G., et al (1990) Acamprosate appears to decrease alcohol intake in weaned alcoholics. Alcohol and Alcoholism, 25, 613-622.
13. MacKenzie, A., Funderburk, F. R., Allen, R. P., et al (1987) The characteristics of alcoholics frequently lost to follow-up. Journal of Studies on Alcohol, 48, 119-123.
14. Marlatt, G. A. & Gordon, J. R. (1985) Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviours. New York: Guilford Press.
15. Naranjo, C. & Bremner, K. (1992) Evaluation of the effects of serotonin uptake inhibitors on alcoholics. In Novel Pharmacological Interventions for Alcoholism (eds C. Naranjo & E. Sellers), pp. 104-117. New York: Springer-Verlag.
16. Nathan, P. E. & Skinstad, A.-H. (1987) Outcomes of treatment for alcohol problems: current methods, problems and results. Journal of Consulting end Clinical Psychology, 55, 332-340.
17. O'Malley, S. S., Jaffe, A. J., Chang, G., et al (1992) Naltrexone and coping skills therapy for alcohol dependence. Archives of General Psychiatry, 49, 881-887.
18. Paille, F. M., Guelfi, J. D., Perkins, A. C., et al (1995) Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol. Alcohol and Alcoholism, 30, 239-248.
19. Pelc, I., Le Bon, O., Verbanck, P., et al (1992) Calcium-acetylhomotaurinate for maintaining abstinence in weaned alcoholic patients: a placebo-controlled double-blind multicenter study. In Novel Pharmacological Interventions for Alcoholism (eds C. A. Naranjo & E. M. Sellers), pp. 348-352. New York: Springer-Verlag.
20. Sass, H., Soyka, M., Mann, K., et al (1996) Relapse prevention by acamprosate: results from a placebo controlled study on alcohol dependence. Archives of General Psychiatry, 53, 673-680.
21. Vaillant, G. E. (1988) What can long-term follow-up teach us about relapse and prevention of relapse in addiction? British Journal of Addiction, 83, 1147-1157.
22. Verbanck, P. (1995) The pharmacological treatment of alcoholism. From basic science to clinical medicine. Alcohol and Alcoholism, 30, 757-764.
23. Volpicelli, J. R., Alterman, A. I., Hayashida, M., et al (1992) Naltrexone in the treatment of alcohol dependence. Archives of General Psychiatry, 47, 876-880.
24. Whitworth, A., Fischer, F., Lesch, O. M., et al (1996) Comparison of acamprosate and placebo in long-term treatment of alcohol dependence. Lancet, 347, 1438-1442.
25. Zeise, M. L., Kasparow, S., Capogna, M., et al (1990) Calciumdiacetylhomotaurinate (Ca-aota) decreases the action of excitatory amino acids in the rat neocortex in vitro. Progress in Clinical Biological Research, 351, 237-242.